Author

Leslie Gallardo

Pfizer (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Approach:experimental assay· 1 Assay:proteomics· 1

Frequent Co-Authors

Annalena La Porte· 1 shared Arthur Illenberger· 1 shared Cara Kobylarz· 1 shared Christopher Ponce· 1 shared Danielle E. BaranovaiD· 1 shared Elizabeth KepliD· 1 shared Jacqueline Lypowy· 1 shared L Liu· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Annalena La Porte

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Improving the immunogenicity of E. coli FimH via multivalent display on I53-50 nanoparticles

Rebecca S Cole, Natalie C. Silmon de Monerri, Jacqueline Lypowy, Christopher Ponce, Cara Kobylarz, L Liu, Zein Kasbo, Elizabeth Kepl, Tara Ciolino, Arthur Illenberger, Leslie Gallardo, Annalena La Porte, Danielle E. Baranova, Rashmi Ravichandran, Laurent Chorro, , Neil P. King

This paper improves the immunogenicity of E. coli FimH by displaying it on I53-50 nanoparticles, achieving comparable antibody responses to higher doses of monomeric FimH with reduced adjuvant needs.

Frontiers in Immunology · Jul 21, 2026Peer-reviewedImmunology